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opiomelanocortin (POMC), the common prohormone for
the peptide hormones (Figure 1A): adrenocorticotropin
(ACTH), b endorphin, and a melanocyte–stimulating hor-
Summary mone (a-MSH) (Nakanishi et al., 1979). POMC, synthe-
sized primarily in the intermediate and anterior pituitary
A proposed mechanism for sorting secretory proteins and in the brain, is packaged into the granules of the
into granules for release via the regulated secretory RSP (Loh and Gritsch, 1981; Loh et al., 1984a; Loh and
pathway in endocrine-neuroendocrine cells involves Tam, 1985), where it is correctly cleaved at paired-basic
binding the proteins to a sorting receptor at the trans- residues to biologically active peptide hormones. Us-
Golgi network, followed by budding and granule for- ing chimeras made from portions of POMC, fused to
mation. We have identified such a sorting receptor as the reporter protein, chloramphenicol acetyltransferase
membrane-associated carboxypeptidase E (CPE) in (CAT) (Tam et al., 1993), and deletion–amino acid substi-
pituitary Golgi-enriched and secretory granule mem- tution analysis of full-length POMC (Cool and Loh, 1994;
branes. CPE specifically bound regulated secretory Cool et al., 1995), we showed that the N-terminal POMC
pathway proteins, including prohormones, but not residues 8–20 contain an amphipathic loop conforma-
constitutively secreted proteins. We show that in the tional motif stabilized by one disulfide bridge (Figure
Cpefat mutant mouse lacking CPE, the pituitary prohor- 1B), which is sufficient and necessary for sorting POMC
to the RSP. Similar sorting signal motifs have been iden-mone, pro-opiomelanocortin, was missorted to the
tified for chromograninB (Chanat et al., 1994) and proen-constitutive pathway and secreted in an unregulated
kephalin (Bamberger et al., unpublished data).manner. Thus, obliteration of CPE, the sorting recep-
A sorting signal alone is not sufficient to cause sortingtor, leads to multiple endocrine disorders in these ge-
to the RSP. In 1987, Orci et al. suggested that condens-netically defective mice, including hyperproinsulin-
ing prohormones are linked tightly to the membranes ofemia and infertility.
the budding granules, thereby preventing entry of other
proteins into the bud. Because of the selectivity with
Introduction which prohormones are sorted to the RSP and their tight
linkage to the membranes, we proposed that the most
Secretory proteins in general are released from cells logical mechanism for sorting neuroendocrine proteins
via a nonregulated constitutive pathway. However, in to the RSP would be via a receptor-mediated mecha-
neuroendocrine cells of the nervous and endocrine sys- nism, as was previously also proposed (Kelly, 1985; Tam
tems, there is also a regulated secretory pathway (RSP) et al., 1993). In this model, the sorting signal would bind
from which hormones, neuropeptides, and the granins specifically to a “receptor” located in the TGN, and this
are secreted in a calcium-dependent manner. The larger complex would be stable until the prohormone was
inactive proforms of these peptide hormones and neuro- packaged into the regulated secretory granule, at which
peptides are packaged into the granules of the RSP point the prohormone could be processed and stored
and are processed to active peptides intragranularly, in the SGs.
although early processing steps may occur at the trans- We now show that POMC and other neuroendocrine
Golgi network (TGN). Thus, failure to package the pro- proteins (proinsulin, proenkephalin, and chromogranin
hormones or proneuropeptides into the regulated secre- A) can bind specifically to TGN and SG membranes of
tory granules (SGs) could lead to endocrine and nervous bovine intermediate pituitary. The receptor with which
system disorders due to incomplete processing and un- these proteins specifically interacts is shown here to be
regulated secretion of unprocessed or partially pro- the membrane-associated form of carboxypeptidase E,
cessed precursors. It is at the level of the TGN that (CPE; also named carboxypeptidase H), implicating this
neuroendocrine and other proteins destined for the reg- protein as vital in the RSP. The importance of CPE for
ulated pathway are separated from constitutively se- regulated secretion was demonstrated in two models:
creted proteins (Orci et al., 1987; Sossin et al., 1990). a mouse neuroendocrine cell line (Neuro-2a) in which
CPE expression was down-regulated by antisense RNA,The specific sorting of RSP proteins away from those
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Figure 1. Schematic Diagram and Molecular
Model of Bovine POMC
(A) Hatch marks show the signal peptide in
bovine POMC. Disulfide bridges (-S-S-) and
the RSP sorting signal region are shown in
the N-terminus. JP, joining peptide; CLIP,
corticotropin-like intermediate lobe peptide;
K, Lys; and R, Arg.
(B) Three-dimensional molecularmodel of the
NH2-terminal region of POMC. The figure
shows the Cys8–Cys20 disulfide bridge and
the 13 amino acid amphipathic loop sorting
signal.
and the genetically defective Cpefat mouse, lacking CPE al., 1995) where sorting occurs and at the intragranular
pH of between 5–6 (Loh et al., 1984b).(Naggert et al., 1995). POMC was missorted to the con-
stitutive pathway in both of these systems. These stud- To show that the POMC sorting signal was binding
specifically to the lumenal side of the SG membranes,ies provide evidence that sorting neuroendocrine pro-
teins to the RSP requires binding to a sorting receptor, binding to lysed intermediate lobe SG membranes (lu-
menal side) and intact SG’s were compared. Binding toCPE, within the TGN and elucidate themolecular mecha-
nism for the endocrine disorders observed in the mutant lysed SG membranes was well above background (28 6
1 pmol/mg protein) and was inhibited by unlabeledCpefat mouse.
N-POMC1–26, whereas binding to the membrane on the
cytoplasmic side of freshly prepared SGs was negligi-Results
ble and represented only background (<1 fmol/mg pro-
tein). Binding was also minimal (<100 fmol/mg protein)The POMC Sorting Signal Binds Specifically
to Golgi-enriched membranes from the nonendocrine Lto a Sorting Receptor
cell line compared to the Golgi-enriched membranesThe proposed mechanism for sorting proteins to the
from bovine intermediate pituitary (104 pmol/mgRSP is that an amphipathic loop sorting signal motif
protein). Similarly, [125I]N-POMC1–26 did not bind to the(Figure 1B), located in the prohormone, binds specifi-
plasma membranes of Neuro-2a cells, although it didcally to a membrane-associated receptor in the lumen
bind to SGs prepared from Neuro-2a cells. Thus, [125I]N-of the TGN, which causes the protein–receptor complex
POMC1–26 binding was specific to the lumenal side ofto be packaged within the budding immature SG. Having
the SGs.identified the sorting signal for POMC (Tam et al., 1993;
Further characterization of [125I]N-POMC1–26 binding toCool and Loh, 1994; Cool et al., 1995), we looked for
the receptor showed that Ca21 (1 mM–100 mM) had noproteins in the TGN and SG membranes that could bind
effect (29 6 1 pmol/mg protein for control SG mem-this sorting signal with high affinity and selectivity.
branes versus 28 6 0.3 pmol/mg protein for Ca21The POMC sorting signal was iodinated ([125I]-N-
treated). Treatmentof themembranes with thesulfhydrylPOMC1–26), and its binding to SGs was assayed over a
group-specific reagents, N-ethylmaleimide and iodo-range of pH’s. The [125I]-N-POMC1–26 sorting signal binds
acetamide, which are specific for free cysteines, inhib-to bovine intermediate lobe SG membranes optimally
ited the [125I]N-POMC1–26 binding >75% and 90%, respec-between pH 5.0 and 6.0 (Figure 2A). Under similar pH
tively, indicating that they acted on a free cysteineconditions, the optimal pH for [125I]-N-POMC1–26 binding
residue in the receptor. However, addition of these re-to Golgi-enriched membranes was found to be 6.0–6.5
agents at the initiation of the binding reaction in the(Figure 2B). Full-length POMC was found to have an
presence of [125I]N-POMC1–26 had no effect, indicatingoptimum pH range for binding to SG and Golgi-enriched
they they were not acting on the ligand.membranes around pH 6.0 (Figures 2C and 2D, respec-
The effect of increasing concentrations of N-POMC1–26tively). These results show that POMC can bind the sort-
ing receptor at the TGN lumenal pH of 6.2 (Seksek et on [125I]N-POMC1–26 binding to intermediate lobe SG
Regulated Secretory Pathway Sorting Receptor
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Figure 3. Prohormones Bind Specifically to the Sorting Receptor
(A) Dose-dependent displacement of [125I]N-POMC1–26 binding to SGs
with unlabeled N-POMC1–26 (open squares). IgG (closed squares)
was also used in place of unlabeled N-POMC1–26 to show that a
constitutively secreted protein did not provide dose-dependent dis-
placement of [125I]N-POMC1–26 binding.
(B) The efficacy of 100 mM N-POMC, proinsulin (PI), proenkephalin
Figure 2. pH-Dependent Binding of [125I]N-POMC1–26 to Intermediate (PEnk), chromogranin A (CGA), IgG (IgG), met-enkephalin (ME),
Lobe SG membranes and Golgi-Enriched Membranes ACTH1–39 (39), ACTH1–14 (14), b endorphin (b-E), and proalbumin–
[125I]N-POMC1–26 binding was determined for SG (A) and Golgi- Christchurch (AC) to inhibit N-POMC1–26 binding to SG membranes
enriched microsomal membranes (B) over a range of pH’s. Binding of was determined. Subsequently, the inhibition of each protein’s bind-
full-length [35S]met-POMC to SG membranes (C) and Golgi-enriched ing by unlabeled N-POMC1–26 was also determined.
microsomal membranes (D) was also determined over the same pH
range. N-POMC1–26 binding (100%) to SG membranes and Golgi-
enriched membranes was 50 pmol/mg protein. POMC binding to SG
endorphin, proalbumin–Christchurch,[35S]D2-26-POMC,and Golgi-enriched membranes was 20 pmol/mg protein. Specific
and proalbumin (data not shown) did not bind to thebinding was determined by subtracting binding in the presence of
100 mM N-POMC1–26 (750–4000 CPM). SG membranes and were not displaced by N-POMC1–26,
further indicating that thebinding of [125I]N-POMC1–26 was
specific. Unlabeled N-POMC1–26 (100 mM) had a high
relative potency for displacing [125I]N-POMC1–26 bindingmembranes at pH 5.5 was investigated. N-POMC1–26 dis-
placed [125I]N-POMC1–26 with an IC50 of 65 mM (Figure 3A), (Figure 3B). Full-length POMC and other prohormones
showed a high potency for displacement of [125I]N-and Scatchard analysis showed a Kd of 6 mM and Bmax
of 580 pmol/mg protein (Cool et al., unpublished data). POMC1–26 binding and for being displaced by N-POMC1–26
(Figure 3B). The rank order of potency was N-POMC1–26>As a control, [125I]N-POMC1–26 binding was not inhibited
by the constitutively secreted protein, IgG (Figure 3A). proinsulin>proenkephalin>POMC> chromogranin A.
Binding to Golgi-enriched membranes gave similar re-
sults. Identification of the Sorting Receptor as CPE
To identify the receptor responsible for binding theThe specificity of the binding of the POMC sorting
signal to the sorting receptor in bovine intermediate POMC sorting signal, chemical cross-linking studies
were carried out using EDC, a cross-linking reagent thatlobe SG membranes was assessed. In the relative po-
tency curve (Figure 3B), the peptide hormones from do- reacts with an aspartic or glutamic side chain and cou-
ples one protein to another via an amine group. [125I]N-mains of POMC other than the sorting signal (ACTH1–39,
ACTH1–14, b endorphin, and met-enkephalin [b endor- POMC1–26 was cross-linked to a 55 kDa protein in SG
membranes, as determined by SDS–polyacrylamide gelphin1–5]), IgG and proalbumin–Christchurch had a low
potency for displacing the [125I]N-POMC1–26 binding. Like- electrophoresis (PAGE) (Figure 4A, lane 1). Displace-
ment of the binding with N-POMC1–26 resulted in thewise, iodinated ACTH1–14, ACTH1–39, met-enkephalin, b
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affinity-purified protein, which was cross-linked to the
[125I]N-POMC1–26 ligand, was further identified as CPE by
Western blot (Figure 4B, lanes 6 and 7). After extraction
of bovine SG membranes with 1.5 M KSCN, there was
an 87% depletion of CPE in the membranes and an
89% reduction in [125I]N-POMC1–26 binding to the CPE-
depleted membranes, further demonstrating the speci-
ficity of the binding receptor.
Obliteration of CPE Expression by Antisense
RNA Causes Missorting of POMC
in Neuro-2a Cells
To evaluate the functionality of CPE as a sorting receptor
in vivo, we generated stable Neuro-2a cell lines express-
ing antisense to CPE (Neuro-2a-CPEAS), transfected
POMC cDNA into these cells, and assayed them by
immunocytochemistry and in secretion studies. In wild-
type Neuro-2a cells, immunoreactive ACTH (ACTHi) was
found in punctate granules, characteristic of the RSP,
Figure 4. Identification of the [125I]N-POMC Binding Protein as CPE located in the cell body, neurites and at the tips of the
(A) Identification of the binding protein as a 55 kDa band by EDC neurites (Figure 5A). The localization of the Golgi in the
cross-linking of [125I]N-POMC1–26 to the SG membranes. Lanes 1 and cell was indicated by fluoroscein isothiocyanate–wheat
2 show the 55 kDa band (arrow) from SG membranes in the absence germ agglutinin staining (Figure 5B). On the contrary,
or presence of 100 mM N-POMC1–26. Lanes 3 and 4 show the same when POMC was expressed in the Neuro-2a-CPEAS cellsize band from Golgi-enriched membranes. Lane 5 is from a Coo-
lines (clones CPEAS-6 and CPEAS-7), which showed >massie blue stained gel showing pooled fractions eluted from an
80% depletion of CPE (Figure 6A), the ACTHi was foundN-POMC1–26 affinity column. The heavily stained band corresponds
to the previously identified bands. Lanes 6 and 7 show the affinity- localized in a perinuclear area (Figures 5C and 5E), sug-
purified protein from lane 5 after [125I]N-POMC1–26 binding in the gesting it was in the Golgi and endoplasmic reticulum
presence or absence of N-POMC1–26, followed by cross-linking and as identified by the wheat germ agglutinin staining (Fig-
SDS–PAGE. Molecular weight markers are shown to the right of the
ures 5D and 5F). The lack of ACTHi staining in punctatelanes.
granules suggests that the reduction of CPE in these(B) Western blot identification of CPE as the binding protein. Follow-
cells caused a loss of sorting to the RSP granules.ing binding and cross-linking, a duplicate sample of proteins in
section 4A were transferred to nitrocellulose and probed with The hallmark of the RSP is the secretion of proteins
CPH7-4. In lanes 1–7, the blot shows that the amount of CPE in in response to a stimulus. The effect of high K1/Ca21
each pair of lanes is identical and that the 55 kDa band (arrow) depolarization on release of POMC from wild2type and
identified by cross-linking is CPE.
Neuro-2a-CPEAS clones was investigated. In Neuro-2a
cells, ACTHi was released from the cells in response to
K1/Ca21 depolarization, yielding a 3.5-fold stimulationdisappearance of the iodinated 55 kDa protein (Figure
4A, lane 2), suggesting that this was a specific binding (Figure 6B). When POMC cDNA was transfected into the
Neuro-2a-CPEAS cell lines, the amount of ACTHi releasedand cross-linking. A single band was also found in mem-
branes from the Golgi-enriched fraction, which was sen- without stimulation for clones CPEAS-6 and CPEAS-7 was
27% and 38% of the total, respectively (Figure 6B). Withsitive to N-POMC1–26 (Figure 4A, lanes 3 and 4).
The binding protein was purified using an N-POMC- stimulation, the amounts released were about the same,
28% and 33% of the total, respectively, compared withaffinity column and analyzed on SDS–PAGE followed by
Coomassie blue staining. A heavily stained protein was the wild-type Neuro-2a cells, which only released 12%
of the total ACTHi basally and 42% upon stimulation.identified as being the same size as that obtained using
EDC cross-linking (Figure 4A, lane 5). Similarly, CPE was also released in a stimulated manner
from wild-type Neuro-2a cells. CPE (16%) was secretedTo verify this band as the N-POMC receptor, the affin-
ity-purified protein was incubated with [125I]N-POMC1–26 basally and 26% upon stimulation with K1/Ca21, show-
ing a 1.6-fold stimulation of secretion. The full-length,and cross-linked using EDC. This procedure yielded one
protein that was cross-linked with [125I]N-POMC1–26 in an membrane-associable form of CPE was the predomi-
nant (>90%) form of CPE released. The release of highN-POMC1–26 sensitive manner (Figure 4A, lanes 6 and 7).
N-terminal amino acid sequencing of the purified sorting levels of ACTHi in a nonstimulatable manner suggests
that the Neuro-2a-CPEAS cells are releasing the ACTHireceptor showed a 97% homology with the N-terminal
of bovine CPE (EC 3.4.17.10). The single-letter code constitutively. In addition, unprocessed, full-length POMC
was the major component released from these cellsamino acid sequence was HPQEDGISFEYHRYPELREA.
Subsequent probing with C-terminally directed antibod- (data not shown), providing further evidence that POMC
was not packaged with the processing enzymes in theies (CPH7-4) showed that [125I]N2POMC1–26 was binding
to a membrane-associated form of CPE (Figures 4B, regulated SGs but rather exited the cellsvia theconstitu-
tive (default) pathway (Matsuuchi and Kelly, 1991). Thelanes 1 and 3) and that this binding was displaced by
N-POMC1–26 (Figure 4B, lanes 2 and 4). Probing of the results clearly indicate that CPE is required for sorting
of POMC to the RSP. SG membranes prepared fromaffinity-purified protein with antibodies to CPE showed
a single band (Figure 4B, lane 5). The single band of CPEAS-deficient cell lines lack [125I]N-POMC1–26 binding
Regulated Secretory Pathway Sorting Receptor
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Figure 5. Immunocytochemical Localization of POMC in Neuro-2a Cells or CPEAS Clones
Rhodamine staining for ACTHi is shown for Neuro-2a cells (A) or clones CPE2AS-6 (C) and CPE2AS-7 (E) transfected with cDNA for POMC. (B),
(D), and (F) show the corresponding fluoroscein isothiocyanate–wheat germ agglutinin staining of the Golgi for each of the cells in (A), (C),
and (E), respectively. Punctate granules in (A) are indicated by the white arrows; punctate granules in the tips of neurites are indicated by
large white arrowheads. ACTHi staining in the Golgi and ER is indicated in (C) and (E) by the black arrows. In (B), (D), and (F), the small white
arrowheads indicate Golgi staining. Scale bar 5 10 mm.
(0.18 6 0.07 pmol/mg protein) compared to SG mem- and Smelik, 1975). We assayed for the release of POMC-
derived ACTH peptides from the intermediate lobe ofbranes from wild-type Neuro-2a cells (14 6 2 pmol/mg
protein). normal mice and the Cpefat mutant strain of mice lacking
CPE (Naggert et al., 1995) to further determine if CPE
is essential for sorting POMC to the RSP in vivo.Pituitary POMC Is Missorted to the Constitutive
Pathway in the Cpefat Mouse The time course of release of [35S]met-POMC/ACTH
products from the intermediate lobe of normal and CpefatThe Cpefat mouse has a mutation in the Cpe gene, yield-
ing an enzyme that is rapidly degraded (Varlamov et al., mice after pulse labeling and various chase times is
shown in Figure 7A. Cpefat mice showed an initial lag of1996). Unlike normal mice, Cpefat mice had virtually no
detectable CPE in the endocrine tissues, which normally 15 min, followed by linear release of [35S]met-POMC/
ACTH above normal animals, over 3 hr. This fast timecontain high levels of CPE (Naggert et al., 1995). The
pituitary intermediate lobe of mammals secretes POMC- course of release of [35S]met-POMC/ACTH is character-
istic of constitutive secretion (Grimes and Kelly, 1992).derived ACTH peptides from granules of theRSP. Secre-
tion of POMC–ACTH peptides from this tissue is under In contrast, normal mice showed significant release of
[35S]met-POMC/ACTH only after 1 hr. The longer lag timeinhibitory control by dopamine, released tonically from
dopaminergic nerve fibers innervating the lobe (Tilders before release in normal animals is typical of secretion
Cell
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Figure 7. Constitutive Secretion of [35S]met-POMC from Intermedi-
ate Lobes of Cpefat Mouse Pituitary
(A) Time course of secretion of POMC. Intermediate lobes of Cpefat
and normal mice were pulse-labeled and chased for various times.
The tissue homogenate and chase medium were immunoprecipi-
tated with ACTH antiserum, and the immunoprecipitates were
counted. CPM in the medium was expressed as a % of the total
(total CPM 5 CPM in medium 1 CPM in tissue). The curve for normal
mice is denoted by open squares and Cpefat mice by (*).
(B) The effect of dopamine on POMC secretion. Pulse-labeled inter-
Figure 6. Depletion of CPE Causes Constitutive Secretion of POMC mediate lobes were chased for 2 hr with or without dopamine (DA),
from Neuro-2a Cells and the tissue and medium were immunoprecipitated with ACTH
antiserum. The CPM in the medium was first normalized to % CPM(A) Generation of Neuro-2a cells stably expressing antisense RNA
in medium divided by the total CPM (tissue 1 medium). Samplesfor CPE. Western blot analysis of Neuro-2a cells or CPEAS-6 and
without treatment with dopamine were used as controls and madeCPEAS-7 clones shows the relative amount of CPE in the cells. M,
equal to 100%, and the medium with dopamine was expressed asmembrane-associated CPE; S, soluble form. The membrane-associ-
a % of the control. Bar graphs show the mean 6 SEM in the mediumated form represents >90% of the total CPE found in the SGs. The
with DA as a % of control. For normal control, n 5 3; n 5 2 forcorresponding reduction in CPE is shown in the bar chart above
normal 1 DA (asterisk, p < 0.01); n 5 2 for Cpefat control; n 5 3 foreach lane.
Cpefat 1 DA.(B) Regulated secretion of POMC from Neuro-2a cells requires CPE.
(C) SDS gel analysis of ACTH immunoprecipitates from medium andNeuro-2a or CPEAS-6 and CPE2AS-7 were transfected with a vector
tissue. Representative gels of medium and tissue derived from thecontaining the cDNA for POMC, and the cells were stimulated to
experiment described in (B). Samples were loaded onto a 16% SDS-release POMC. The bar graph shows the quantitation of the release
Tris-glycine gel, followed by electrophoresis and autoradiography.data as the amount of ACTHi released into the medium during the
second incubation divided by the total amount of ACTHi present in
media 1 1 media 2 1 cell extract and is expressed as % released
into media. The data in the bar graph represents the average 6 Dopamine had no effect on the release of [35S]met-
SEM from three experiments. The total amount of ACTHi expressed POMC/ACTH products from the intermediate lobe ofby each well of cells was determined by radioimmunoassay to be
Cpefat mice, indicating constitutive secretion (Figure 7B).the same, z200 6 50 pmol/well.
In contrast, release from normal mice was regulated by
dopamine, showing a 79% inhibition. Analysis of the
POMC–ACTH products by SDS gels in the 2 hr chasethrough the RSP (Loh and Gainer, 1977), due to the
slower packaging of POMC into regulated SGs. More- medium, with and without dopamine, showed that
POMC was the primary component secreted into theover, the higher amounts of [35S]met-POMC/ACTH prod-
ucts released in Cpefat mice compared to normal mice medium from intermediate lobes of Cpefat and normal
mice (Figure 7C). In the absence of dopamine regulationis also consistent with more rapid constitutive secretion
of POMC–ACTH from the intermediate lobe. in vitro, release of newly synthesized POMC–ACTH from
this tissue in normal mice is constant, resulting in insuffi-To further substantiate that in Cpefat mice the release
of POMC–ACTH from the intermediate lobe is constitu- cient time for complete POMC processing prior tosecre-
tion. Hence, POMC is the major component released intive, the effect of dopamine on secretion was examined.
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normal mice, but it was inhibited by dopamine (Figure POMC can bind at the lumenal pH (z6.2) (Seksek et al.,
1995) of the TGN where sorting to the RSP takes place.7C). In contrast, the release of POMC from Cpefat mice
was not inhibited by dopamine (Figure 7C). While POMC These findings are consistent with previous in vivo data
showing that the correct sorting of proteins to the RSP,was the major component in the tissue, some POMC
processing was observed in normal and Cpefat mice, such as POMC and secretogranin II, requires an acidic
pH (Gerdes et al., 1989; Carnell and Moore, 1994).with and without dopamine present (Figure 7C). In nor-
mal mice, the 1.5 kDa ACTH was the major processed Ca21 is found in the Golgi and SGs (Bulenda and Grat-
zel, 1985; Chandra et al., 1991) and is required for theproduct, whereas in Cpefat mice, there was very little 1.5
kDa ACTH present (Figure 7C). Instead, some larger aggregation and processing of prohormones by some
of the enzymes in the RSP (Estivariz et al., 1989; CarnellACTH processed products, 21 kDa, 13 kDa, and 4.5
kDa, were present, presumably cleaved by processing and Moore, 1994). However, Ca21 was not required for
binding, nor did its presence inhibit binding. This is con-enzymes in the TGN. The 1.5 kDa product (ACTH1–14) is
normally further modified at the N- and C-termini to yield sistent with findings in semi-intact cells reported by
other groups showing that Ca21 is not required for sort-a-MSH, a final POMC processed product in this tissue.
Cleavage of 13 kDa (glycosylated form of 4.5 kDa ACTH) ing of POMC and secretogranin II to the RSP (Carnell
and Moore, 1994; Chanat et al., 1994).and 4.5 kDa ACTH1–39 to form 1.5 kDa ACTH is a late
processing step, carried out by an enzyme, PC2, that Do all prohormones and other proteins sorted to the
RSP utilize CPE as their receptor? Transfection of vari-functions most efficiently only in the SGs (Loh and
Gritsch, 1981; Benjannet et al., 1991; Thomas et al., ous prohormone cDNA’s into the endocrine cell line
AtT20 have yielded expressed prohormones that were1991; Zhou et al., 1993). The virtual lack of 1.5 kDa ACTH
formation in Cpefat mice is therefore consistent with targeted to the RSP (Moore et al., 1983), suggesting that
perhaps there is a common sorting receptor. Our studiesPOMC not being packaged into the regulated SGs. Thus,
in the absence of CPE, the sorting receptor, POMC was showing the displacement of N-POMC1–26 by POMC,
proenkephalin, proinsulin, and chromogranin A arguesmissorted and secreted via the constitutive pathway in
an unregulated manner from the intermediate lobe of for a common receptor. Furthermore, the similarity of
the affinity constant, Kd, and the number of bindingCpefat mice.
sites, Bmax, in the secretory granule membranes for
N-POMC1–26, proinsulin and proenkephalin (Cool et al.,
Discussion unpublished data) further suggest that one receptor,
CPE, can sort these prohormones.
CPE Is the Regulated Secretory Pathway
Sorting Receptor
We have provided evidence for a sorting receptor in Characteristics of the Sorting Receptor
The membrane-bound form of CPE was first isolatedbovine intermediate pituitary Golgi-enriched and SG
membranes and characterized it. This receptor has been from chromaffin granules and has been reported to have
a molecular weight of 55 kDa (Fricker and Snyder, 1983;identified as membrane-associated CPE based on its
N-terminal amino acid sequence,size, and immunoreac- Fricker et al., 1986), similar to that determined by our
cross-linking studies of [125I]N-POMC1–26 with the recep-tivity with an antiserum that specifically recognized the
membrane form. It has the capacity to specifically bind tor. It has an amphipathic tail at the C-terminus (Fricker
et al., 1990; Varlamov and Fricker, 1996). It has beenN-POMC1–26 containing the 13 amino acid amphipathic
loop (N-POMC8–20) RSP sorting signal of POMC, full- proposed that the hydrophobic residues in the amphi-
pathic tail are buried in the lipid bilayer or interact withlength POMC, proinsulin, proenkephalin, and chro-
mogranin A, in an N-POMC1–26 displaceable manner. Mu- membrane-bound proteins and are responsible for the
tight association of CPE with the membrane (Fricker,tated POMC from which the N-terminal aminoacids 2–26
(the sorting signal) have been removed does not bind. 1988; Fricker et al., 1990). Our studies show that 1%
Triton X-100 was unable to extract CPE from the bovineThe receptor does not bind constitutively secreted pro-
teins such as proalbumin and IgG. The Scatchard plots intermediate lobe SG membranes, confirming the strong
association of CPE with SG membranes (Cool, unpub-(Cool et al., manuscript in preparation) and dose-depen-
dent displacement curves obtained for N-POMC1–26 lished data). The membrane form of CPE has low enzy-
matic activity when it is associated with SG membranesbinding to Golgi-enriched and SG membranes are char-
acteristic of a low affinity, single binding site type of (Fricker et al., 1990). The tail is cleaved off proteolytically
to yield the enzymatically more active soluble form al-receptor.
It has been shown in intact cells that a low pH at the though as much as 90% of the CPE remains membrane-
associated in the granules (Fricker et al., 1990: numberTGN is necessary for sorting POMC to the RSP (Burgess
and Kelly, 1987; Gerdes et al., 1989). We have now dem- 150; Varlamov et al., 1996: number 479; Cool, unpub-
lished data). Moreover, a small amount of full-length, 55onstrated in vitro that [125I]N-POMC1–26, which contains
the POMC sorting signal, as well as full-length POMC kDa membrane CPE has also been found in the soluble
fraction of bovine pituitary SGs (Parkinson, 1990) andbinds to a receptor in Golgi-enriched and SG mem-
branes from endocrine pituitary cells and neuronal cell shown to be released in a regulated manner from mouse
pituitary (Cool et al., unpublished data).lines optimally at acidic pH’s ranging from 5.0–6.5. The
optimum pH for binding full-length POMC, chromo- There are seven cysteine residues in CPE, but there
has been no detailed study showing which cysteinesgranin A, and proinsulin was between pH 6.0–6.5. Thus,
the optimal pH range for the binding of POMC to the are bonded and which are free. One or more of these
cysteine residues may be involved in the binding of thesorting receptor from the in vitro studies indicates that
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N-POMC1–26 ligand, as suggested by our data showing propose that the protein aggregates to form a complex
prior toor during binding, although this is not a prerequi-inhibition of binding after pretreatment of SG mem-
branes with sulfhydryl group-specific reagents. Further site for interaction with the receptor. Formation of the
protein-ligand-receptor complex could perhaps triggerstudies are necessary to determine the molecular inter-
action of the N-POMC1–26 sorting signal with its binding budding, leading to the generation of an immature secre-
tory granule and delivery of the complex into the formedsite on CPE and more specifically with the cysteine
residue. granule.
The ligand–receptor complex and the aggregates may
dissociate within the milieu of the maturing granule orCPE Functions as a Sorting Receptor In Vivo
during exocytosis. The fate of CPE, the sorting receptor,The demonstration that transfected POMC was not tar-
once in the granule is unknown. Since a significantgeted to SGs of the RSP, but secreted constitutively in
amount of CPE remains associated with the SG (FrickerNeuro-2a-CPEAS cells depleted of CPE by CPE antisense
et al., 1990), perhaps only some of the CPE moleculesRNA expression, clearly shows that CPE plays a pivotal
are cleaved at the C-terminal amphipathic tail to yieldrole insorting POMC in intact cells. Moreover, the finding
the more active soluble enzyme. As CPE catalyzes athat in the Cpefat mutant mouse, POMC was missorted
late prohormone processing step of removal of the basicand secreted constitutively from the intermediate lobe,
residues from products cleaved by the endopeptidases,where this prohormone is synthesized endogenously,
its action in the SGs after first functioning as a sortingprovides additional data in support of a functional role
receptor would not be deleterious. Future studies areof CPE as a sorting receptor in vivo. The Cpefat mouse
necessary to determine if the receptor is attached di-has been reported to have hyperproinsulinemia. It accu-
rectly to the lipid bilayer or to a transmembrane proteinmulated high levels of proinsulin in pancreatic islet cells
and if it is recycled. Our model does not preclude theand had elevated levels of proinsulin in the circulation,
existence of other sorting receptors for different RSPcompared to normal mice (Naggert et al., 1995). This
proteins, but the evidence from our studies suggestsobservation suggests that proinsulin secretion from the
that CPE is a common sorting receptor for many prohor-pancreatic islet cells in vivo in these animals lacking
mones. Since prohormones and granins represent a ma-CPE is constitutive, especially since binding studies
jor component of proteins packaged into regulated SGsshow that proinsulin binds to CPE, the sorting receptor,
in endocrine/neuroendocrine cells, they require directwith similar kinetics to POMC. Thus, the antisense and
binding to a sorting receptor. However, the minor com-Cpefat mouse studies, taken together with the binding
ponents such as the processing enzymes may simplystudies, provide convincing evidence that CPE plays an
coaggregate with the prohormones and be packagedessential physiological role in vivo as a sorting receptor
together, without a specificsorting signal on these mole-in targeting neuroendocrine proteins to the RSP. More-
cules binding directly to the receptor.over, obliteration of CPE, the sorting receptor, can lead
to multiple endocrine disorders besides hyperproinsu-
Experimental Procedures
linemia, obesity, and infertility (Naggert et al., 1995) in
the Cpefat mouse, due to misrouting of prohormones and Materials
N-POMC1–26 was from Peninsula Laboratories (Fullerton, CA) andproneuropeptides to the constitutive pathway, charac-
iodinated by Hazelton Laboratories (Vienna, VA) using [125I]-Bolton-terized by partial or no processing and secretion of ex-
Hunter Reagent (Amersham). Chromogranin A, proinsulin, proen-cessive amounts of biologically inactive precursors. Fu-
kephalin, proalbumin, and proalbumin–Christchurch were iodinated
ture studies on the processing and secretion of other by Hazelton Laboratories using chloramine T. Swine proinsulin, pro-
proneuropeptide and prohormone systems in the Cpefat enkephalin, and chromogranin A were gifts from Novo Nordisk (Den-
mouse will undoubtedly uncover other neuroendocrine mark), Dr. I. Lindberg (Louisiana), and Dr. S. Yoo (NIH), respectively.
Proalbumin and proalbumin–Christchurch (a variant of proalbumindisorders in these animals and reveal a similar mecha-
with a point mutation, Arg22 to Gln22 in the propeptide [Brennannism responsible for them.
and Carrell, 1978]) were gifts from Dr. S. O. Brennan (New Zealand).
Mouse IgG was from Boehringer Mannheim. [35S]-methionine (S.A.
1175 Ci/mmol) was from Amersham. EDC was from Pierce Immuno-A Receptor-Mediated Model for Sorting Proteins
logicals (Illinois).to the Regulated Secretory Pathway
Our present findings support a receptor-mediated
Methods
model for sorting proteins at the TGN of the RSP. There Verification of the Disulfide Bridges in N-POMC1–26
recently has been compelling evidence for the existence The disulfide bridges Cys8–Cys20 and Cys2–Cys24 in the
N-POMC1–26 peptide were verified since the Cys8–Cys20 bridge isof sorting signal motifs necessary for targeting neuroen-
essential for the stabilization of the conformation and function ofdocrine proteins to the RSP (Tam et al., 1993; Chanat
the sorting signal. N-POMC1–26 peptide (3 nmol) were digested withet al., 1994; Cool and Loh, 1994; Cool et al., 1995). These
3 ml of thermolysin (1 mg/ml, Boehringer Mannheim, Indianapolis,
motifs are not represented by a short consensus primary IN) at 378C overnight, injected onto a Vydac C18 high pressure liquid
amino acid sequence but instead by consensus confor- chromatography column, and eluted with a gradient from 0.05%
mation-dependent amphipathic loop structures (Cool et trifluoroacetic acid to 100% acetonitrile over 30 min. Fractions (30
s) were collected and analyzed by fast atom bombardment spec-al., 1995). In our model, the RSP sorting signal on the
trometry (10 KeV Xe, JEOL SX102; Peabody, MA). An examination ofprotein would bind to a sorting receptor, identified in
the ions detected allowed the conclusive placement of the disulfidesthis study as membrane-associated CPE for severalpro-
between Cys2 and Cys24, and Cys8 and Cys20: (a) an ion (MH1)
hormones. Since aggregation of prohormones and chro- 883 represented the link between Cys8 and Cys20 (digest se-
mogranins has been demonstrated (Chanat and Huttner, quences-Ser6 to Asp10 and Leu18 to Cys20); (b) MH1 at 992 for
Cys2 and Cys24 (Trp1 to Cys2 and Ile21 to Pro26).1991; Yoo and Lewis, 1992; Colomer et al., 1996), we
Regulated Secretory Pathway Sorting Receptor
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Preparation of SG and Microsomal Membranes into Sf9 cells (Pharmingen) for 5–7 days. The recombinant virus
containing POMC or -D2-26 was identified by plaque assay andHighly purified SGs and microsomes (PIV fraction) were prepared
from bovine intermediate pituitary and Neuro-2a cells as described purified. For labeling with [35S]-methionine, Sf9 cells were infected
with the recombinant virus-POMC or -D2-26 at a multiplicity of infec-previously (Loh et al., 1984b). The microsomal fraction was highly
enriched with Golgi membranes as evidenced by the highest specific tion of 0.2 and grown for 2 days. The infected Sf9 cells were incu-
bated with 50 mCi/ml of [35S]-methionine in methionine-free mediumactivity of galactosyl transferase, the Golgi marker enzyme in this
fraction, compared to other fractions (Tam et al., 1993). for 4 hr. The medium containing the [35S]met-POMC or [35S]met-D2-
26-POMC was collected and passed through an affinity column toFor binding to the lumenal versus cytoplasmic side of the gran-
ules, the SGs were freshly prepared in a buffer containing 300 mM which an antibody (DP4) against ACTH1–39 was coupled. The column
was eluted with a citrate buffer at pH 3.0; purified [35S]met-POMCsucrose pH 5.5, to maintain the integrity of the granule, and used
or [35S]met-D2-26-POMC were desalted on a G25column and storedimmediately. Extraction of CPE from bovine intermediate lobe SG
at 2808C until use.membranes was carried out by incubating membranes with either
Construction of the Antisense Vector1.5 M KSCN or 1% Triton X100 for 30 min. The extracted SG pellet
Transfections of Neuro-2a cells were performedusing pcDNAIII vec-was resuspended in binding buffer (50 mM MES buffer, 120 mM
tor (Invitrogen). The primers used to create the mouse CPEantisenseNaCl, and 5 mM KCl at pH 5.5).
insert corresponded to sequences 173–197 (sense) and 694–717Binding Assay
(antisense) of the mouse cDNA (GenBank Number X61232). Poly-[125I]N-POMC1–26 binding was assayed as previously described by
merase chain reaction amplification was carried out usingTam et al. (1993) with a few modifications. The total volume of the
the polymerase chain reaction mouse brain cDNA Marathon kitassaywas 200ml binding buffer and 5–10mg protein. [125I]N-POMC1–26
(Clontech).was added to the binding assay to a final concentration of 7 pM for
Generation of Neuro-2a Cells Expressing CPE1 hr, followed by centrifugation at 100,000 3 g for 5 min. The pellet
Antisense mRNAwas counted on a Beckman g counter. Specific N-POMC1–26 binding
Neuro-2a cells were grown in high glucose Dulbecco’s modifiedwas calculated by subtracting the binding measured in the presence
eagle’s medium containing 10% fetal bovine serum as previouslyof 100 mM N-POMC1–26 (i.e., nonspecific) from the total measured in
described (Cool et al., 1995). Stable transformants were made usingthe absence of N-POMC1–26. The binding of [125I]N-POMC1–26,
Lipofectin (Life Technologies) to transfect the plasmid containing the[125I]proinsulin, [125I]proenkephalin, [125I]proalbumin, or [125I]proal-
antisense CPE and were selected using G418 (0.8 mg/ml) selectionbumin–Christchurch to Golgi-enriched or SG membranes was deter-
marker. Out of 300 clones, 5 were selected by Western blot, whichmined in the presence or absence of various concentrations of
showed 50%–93% reduction in CPE expression. Of these, 2 clonesN-POMC1–26 or IgG. Binding conditions for [35S]met-POMC or
(CPEAS-6 and CPEAS-7), which showed 80% and 93% reduction of[35S]met-D2-26POMC were the same as for [125I]N-POMC1–26 except
CPE protein, respectively, were used for the experiments. For thethat, after binding, they were counted in a Beckman LS8000 b
release experiments, CPEAS-6 and CPEAS-7 were plated and tran-counter. For all binding experiments, the data represent the mean
siently transfected with POMC cDNA as described previously (Cool6 SEM (duplicate assays for at least two different membrane prepa-
et al., 1995). An aliquot of the cell extract, media 1 and media 2,rations).
were run on SDS–PAGE; the proteins were transferred to nitrocellu-
lose and blotted using antibodies to POMC and ACTH-related prod-Cross-Linking of [125I]N-POMC1–26 to SG Membranes ucts (DP4-1:2500; [Loh et al., 1985]). The immunoreactive proteinsFollowing the binding assay, SG membranes were resuspended in
were detected by Enhanced Chemiluminescence System. The filmsbinding buffer containing 1 mM EDC and 5 mM N-hydroxyl-succini-
were scanned on a Microtek Scanmaker II using the Adobe Pho-mide for 15 min. The membranes were centrifuged, and the pellet
toshop 3.0.5 software, followed by quantitation using the NIH-Imagewas run on SDS–PAGE; the gel was dried and exposed to film for
1.57 software.2–7 days. The cross-linked band was identified by Western blots
Immunocytochemistry of Neuro-2a cells, and clones CPEAS-6 andwith antiserum against CPE.
CPEAS-7 expressing POMC was performed as previously described
(Cool et al., 1995). Images were captured using a TEC-470 charge-
Antibodies to CPE and Western Blots coupled device color camera on a Nikon Optiphot epifluorescent
Antibodies for CPE were generated to the last 11 residues of full- microscope coupled to a Macintosh 8100/100 PowerPC computer
length CPE (CPEH7-4) or to the first 15 amino acids from the using Adobe Photoshop 3.0.5 software.
N-terminal region of CPE (CPH2-4) and used at a dilution of 1:4000.
Detection of immunoreactive CPE was by Enhanced Chemilumines- Mice
cence System (Amersham). BKS/Cpefat (fat/fat), BKS 1/fat, and BKS 1/1 female mice (7–11
weeks old) were obtained from Dr. E. Leiter (Jackson Laboratory,
Affinity Purification and Microsequencing Bar Harbor, ME). In BKS/CPEfat mice, the mutation (Ser202→Pro202)
of the Membrane Receptor maps to the gene for CPE. BKS 1/fat mice have the same phenotype
N-POMC1–26 was coupled to 3M Emphaze biosupport medium AB1 as BKS 1/1, and both of these strains were pooled and used as
(Pierce, Rockford, IL). Membrane protein (1 mg) was solubilized in normal control animals in this study.
pH 5.5 binding buffer containing 1% b octylglucoside (Pierce) and
passed through the column. After washing with 10 ml of pH 5.5 Pulse2Chase Labeling of Mouse Neurointermediate Lobes
binding buffer, the column was eluted with 10 ml of pH 7.5 binding Pituitary neurointermediate lobes were dissected from mice and
buffer, and 1 ml fractions were collected. Each fraction was desalted incubated at 378C for 15 min in mammalian Ringer’s solution gassed
and run on 10%–20% Tricine/SDS–PAGE. The proteins were trans- with O2. Each lobe was pulse-incubated in Ringer’s solution con-
ferred to polyvinylidene difluoride membrane in a 10 mM Tris–borate taining 1.5 mCi/ml [35S]-methionine for 30 min. After pulsing, the
buffer containing 10% MeOH. The polyvinylidene difluoride mem- labeled lobes were either chase-incubated in Ringer’s solution (with
brane was stained with 0.08% Coomassie blue for 3 s, destained 1 mM unlabeled methionine) and/or homogenized in 0.1 N HCl.
with 50% MeOH, air dried, and the band corresponding to the cross- Homogenates and medium were immunoprecipitated with excess
linked protein (55 kDa) from the cross-linking studies was excised ACTH antiserum, DP4, and DP6 as previously described (Birch and
for sequencing. Amino acid sequence analysis was by Edman deg- Loh, 1989), and the immunoprecipitates were analyzed on 16% SDS
radation using an Applied Biosystems Procise Sequencer (Foster gels followed by autoradiography. In experiments with dopamine,
City, CA) with an on-line phenylthiohydantoin analyzer. the pulse and chase incubation medium also contained 5 mM dopa-
Baculovirus Expression and Affinity Purification mine (Sigma).
of [35S]met-POMC
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